$74.10
0.09[0.12%]
Last update: 1:58PM Get Real Time Here
Intra-Cellular Therapies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Intra-Cellular Therapies using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | AM | ITCI | Q1 | -$0.46 | -$0.33 | — | — | $95.31M | $140.91M | — | — | Get Alert |
02/22/2024 | AM | ITCI | Q4 | -$0.45 | -$0.43 | -$0.30 | 30.23% | $87.87M | $136.79M | $132.10M | -3.43% | Get Alert |
11/02/2023 | AM | ITCI | Q3 | -$0.57 | -$0.56 | -$0.25 | 55.36% | $71.87M | $119.35M | $126.17M | 5.72% | Get Alert |
08/03/2023 | AM | ITCI | Q2 | -$0.92 | -$0.62 | -$0.45 | 27.42% | $55.58M | $106.56M | $110.79M | 3.97% | Get Alert |
05/04/2023 | AM | ITCI | Q1 | -$0.78 | -$0.60 | -$0.46 | 23.33% | $35.00M | $91.98M | $95.31M | 3.62% | Get Alert |
03/01/2023 | AM | ITCI | Q4 | -$1.05 | -$0.59 | -$0.45 | 23.73% | $25.67M | $86.97M | $87.87M | 1.03% | Get Alert |
11/03/2022 | AM | ITCI | Q3 | -$0.95 | -$0.81 | -$0.57 | 29.63% | $22.21M | $66.00M | $71.87M | 8.89% | Get Alert |
08/09/2022 | AM | ITCI | Q2 | -$0.85 | -$0.76 | -$0.92 | -21.05% | $20.05M | $49.02M | $55.58M | 13.38% | Get Alert |
05/10/2022 | AM | ITCI | Q1 | -$0.65 | -$0.92 | -$0.78 | 15.22% | $15.88M | $33.65M | $35.00M | 4.00% | Get Alert |
03/01/2022 | AM | ITCI | Q4 | -$0.76 | -$1.00 | -$1.05 | -5.00% | $12.45M | $25.37M | $25.67M | 1.19% | Get Alert |
11/09/2021 | AM | ITCI | Q3 | -$0.79 | -$0.92 | -$0.95 | -3.26% | $7.37M | $22.12M | $22.21M | 0.39% | Get Alert |
08/09/2021 | AM | ITCI | Q2 | -$0.96 | -$0.80 | -$0.85 | -6.25% | $1.91M | $19.44M | $20.05M | 3.12% | Get Alert |
05/10/2021 | AM | ITCI | Q1 | -$0.73 | -$0.80 | -$0.65 | 18.75% | $1.08M | $16.50M | $15.88M | -3.77% | Get Alert |
02/25/2021 | AM | ITCI | Q4 | -$0.74 | -$0.85 | -$0.76 | 10.59% | $60.61K | $11.84M | $12.45M | 5.19% | Get Alert |
11/09/2020 | AM | ITCI | Q3 | -$0.63 | -$1.00 | -$0.79 | 21.00% | $0.00 | $5.86M | $7.37M | 25.75% | Get Alert |
08/10/2020 | AM | ITCI | Q2 | -$0.68 | -$0.91 | -$0.96 | -5.49% | $0.00 | $3.03M | $1.91M | -37.06% | Get Alert |
05/07/2020 | AM | ITCI | Q1 | -$0.63 | -$0.93 | -$0.73 | 21.51% | $0.00 | $1.44M | $1.08M | -24.79% | Get Alert |
03/02/2020 | AM | ITCI | Q4 | -$0.75 | -$0.81 | -$0.74 | 8.64% | $0.00 | — | $60.61K | — | Get Alert |
11/05/2019 | AM | ITCI | Q3 | -$0.76 | — | -$0.63 | — | $0.00 | — | $0.00 | — | Get Alert |
Intra-Cellular Therapies (ITCI) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 22, 2024 for Q4.
The Actual EPS was $-0.30, which beat the estimate of $-0.43.
The Actual Revenue was $132.1M, which missed the estimate of $136.8M.
Browse earnings estimates, EPS, and revenue on all stocks.